SCHEMBL7698648

SCHEMBL7698648

COc1ccc2[nH]c(C)c(CC(=O)O)c2c1Cc1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.45
KDM4E B2RXH2 4/20 0.44
MAPT P10636 3/20 0.44
GAA P10253 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
PTGS2 P35354 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
PTGDR Q13258 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693001 0.85 AKR1C2 (0.49) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL8671630 0.84 PTGS2 (0.42) KDM4EMAPTGAAALDH1A1PTGS2
SCHEMBL6013487 0.82 AKR1C2 (0.46) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL7698767 0.81 AKR1C2 (0.46) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL3001361 0.80 AKR1C2 (0.53) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL7698626 0.80 GAA (0.49) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL2007216 0.80 AKR1C2 (0.44) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL5496301 0.79 AKR1C2 (0.46) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL9017471 0.79 AKR1C2 (0.47) AKR1C2KDM4EMAPTGAAALDH1A1
SCHEMBL7699710 0.78 AKR1C2 (0.46) AKR1C2KDM4EMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002020478-A1 N-BENZYLINDOLE-3-ACETIC ACID DERIVATIVES FOR USE IN THE TREATMENT OF DRUG RESISTAN CANCER DUBLIN CITY UNIVERSITY (IE) 2002-03-14 WO disclosed